News
HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...
Zacks Investment Research on MSN14h
Core Laboratories Q2 Earnings Beat Estimates, Expenses Increase Y/YCore Laboratories Inc. CLB reported second-quarter 2025 adjusted earnings of 19 cents per share, which beat the Zacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback